Rabinta-Dxr Capsule belongs to a class of medications known as 'dopamine antagonist' used to treat nausea (feeling sick) and vomit (being sick) in adults and adolescents 12 years or older. Besides this, it also helps in the treatment of indigestion. Nausea and vomiting are not diseases but are symptoms of many conditions like infections, motion sickness, an early stage of pregnancy, and gastroparesis (slow stomach emptying).

Rabinta-Dxr Capsule contains domperidone, which prevents nausea and vomiting symptoms by blocking certain receptors (like dopamine and serotonin) that stimulate the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. It also acts as a prokinetic agent that increases the upper gastrointestinal tract's motility and helps decrease stomach emptying time.

Take Rabinta-Dxr Capsule as prescribed by your doctor. Symptoms of nausea and vomiting may usually resolve within 3-4 days after taking Rabinta-Dxr Capsule . However, if it does not resolve even after this, stop taking this medicine and contact the doctor. Do not take Rabinta-Dxr Capsule for longer than seven days. The most common side effect of Rabinta-Dxr Capsule is dry mouth. This side effect is temporary and may resolve after some time; however, if this side persists, contact the doctor.

Do not consume Rabinta-Dxr Capsule if you are hypersensitive to any components present in Rabinta-Dxr Capsule . Before taking the Rabinta-Dxr Capsule , inform your doctor if you suffer from liver or kidney problems. Prolonged intake of Rabinta-Dxr Capsule may be associated with an increased risk of heart rhythm disorder (arrhythmia) and cardiac arrest (heart attack). This risk may be more likely in the elderly (those over 60 years old) or taking doses higher than 30 mg daily. Rabinta-Dxr Capsule is not usually recommended in pregnancy and breastfeeding. But in some cases, domperidone is used to increase milk supply. However, it should be used only during breastfeeding if your physician considers this necessary. Ask your doctor for advice before taking this medicine. Adolescents (children from 12-18 years of age) who weigh less than 35 kg should not be given the Rabinta-Dxr Capsule .

Rabinta-Dxr Capsule contains domperidone, a dopamine antagonist that helps by blocking certain vomiting-inducing receptors in the brain. Rabinta-Dxr Capsule also acts as a prokinetic agent that increases the upper gastrointestinal tract's motility and decreases gastric emptying time. Domperidone is occasionally used to boost milk production. If you're experiencing difficulty nursing, your doctor may prescribe it if nothing else has helped.

Do not consume Rabinta-Dxr Capsule if you are allergic to any components present in Rabinta-Dxr Capsule . Before taking the Rabinta-Dxr Capsule , contact your doctor if you suffer from liver or kidney problems (kidney function impairment or failure). Prolonged intake of Rabinta-Dxr Capsule may be associated with an increased risk of heart rhythm disorder (arrhythmia) and cardiac arrest (heart attack). This risk may be more likely in the elderly (those over 60 years old) or taking doses higher than 30 mg daily. Tell your doctor if you are using anti-fungal medicines and/or if you have heart problems or AIDS/HIV. If you experience heart rhythm disorders like palpitations, trouble breathing, or loss of consciousness after taking the Rabinta-Dxr Capsule , immediately contact your doctor. Domperidone is not usually recommended in pregnancy and breastfeeding. But in some cases, domperidone is used to increase milk supply. However, it should be used only during breastfeeding if your physician considers this necessary. Ask your doctor for advice before taking this medicine. Adolescents (children from 12-18 years of age) who weigh less than 35 kg should not be given the Rabinta-Dxr Capsule .